Yazhou Bay Biomanufacturing Project Roadshow Successfully Held in Sanya Yazhou Bay Science and Technology City

On April 20, the "Yazhou Bay Biomanufacturing Project Roadshow Event," jointly hosted by the China Electronics Information Industry Development Research Institute (CCID), Huada共赢 (Shenzhen) Equity Investment Fund Management Co., Ltd., and China Merchants Sanya Deep Sea Technology City Development Co., Ltd., was successfully held. With the theme of "Technology Leadership · Integrated Innovation," the event attracted representatives from multiple biomanufacturing companies to gather and discuss the development opportunities for the biomanufacturing industry in the Hainan Free Trade Port. Hou Jinfu, Director of the Consumer Goods Industry Department of the Hainan Provincial Industry and Information Technology Department, and Li Boyang, Director of the Consumer Goods Industry Research Institute of CCID, presented on Hainan's biomanufacturing industry and provided an interpretation of industrial policies.

During the project roadshow session, representatives from various companies in the biomanufacturing field shared their core technologies and distinctive innovative projects. Hemus Biotech showcased its globally leading technology in "large-scale production of recombinant human keratin and its medical-grade applications." Zelixir focused on the green manufacturing pathway of "AI + enzymatic synthesis of vanillin," rewriting traditional chemical engineering models. Refinecare Biotech addressed clinical diagnostic challenges with its "multi-pathogen precision detection technology." Nacobiotech drove innovation in bio-based materials through a "synthetic biology platform," replacing highly polluting traditional processes. These four projects cover key areas of biomanufacturing, demonstrating technological breakthroughs and industrial transformation potential.

As the core area for the technology industry in the Hainan Free Trade Port, the Yazhou Bay Science and Technology City High-Tech Zone has attracted over a hundred biopharmaceutical companies through multi-faceted empowerment via "policy + capital + technology." This event further promotes the deep integration of the industrial chain and innovation chain through project roadshows, capital matchmaking, and policy interpretation, attracting more high-quality projects to take root and driving the high-quality development of the biomanufacturing industry.

Project Introduction

1. Hymes (Chongqing) Medical Biotechnology Co., Ltd., with over a decade of focus on recombinant keratin research, has achieved large-scale mass production of recombinant keratin for the first time globally using synthetic biology technology. With a purity as high as 95%, it can meet the raw material needs of brands in fields such as biomedicine and beauty skincare.

2. Zelixir (Shanghai) Biotech Co., Ltd. is an integrated bio-manufacturing company that drives innovation and application in synthetic biology through AI technology, empowering experimental validation, industrialization, and commercialization. It provides high-quality bio-based raw materials and efficient R&D, production, and sales solutions for customers in the fields of food and health, beauty and cosmetics, healthcare, biopharmaceuticals, new materials, agriculture and animal husbandry, and new energy.

3. Ruifengkang Biomedical Technology (Zhejiang) Co., Ltd. has independently developed more than 800 molecular detection products, covering series such as respiratory pathogens, intestinal pathogens, diarrheal pathogens, foodborne pathogens, vector-borne pathogens, hepatitis viruses, reproductive health, and tumors.

4. Hebei Nake Biotechnology Co., Ltd., using synthetic biology technology as its platform, establishes a microbial strain library and a GMP-compliant microbial factory through technologies such as genetic engineering, gene editing, and data simulation. It can scale up the production of degradable new materials like proteins, PHA, PLA, PGA, and industrial enzymes, revolutionarily replacing traditional methods of obtaining materials and active compounds through chemical engineering, animals, and petroleum extraction, avoiding issues like environmental pollution and the spread of animal viruses. It also meets the demand for new materials in the medical, agricultural, environmental protection, and cosmetic fields.

END

Statement:The articles published in this official account are only for promoting communication and learning within the industry;Not for any commercial use, nor does it constitute investment advice.If there are any issues related to infringement or other problems, please contact us for resolution.